Overview
Updated 14 Jul 2026
Myles Wolf, MD, is Sanford I. Weill Chair, Joan and Sanford I. Weill Department of Medicine at Weill Cornell Medicine / NewYork-Presbyterian/Weill Cornell Medical Center. The public record shows 369 publications with 36,330 citations (h-index 93), centered on Parathyroid Disorders and Treatments, Magnesium in Health and Disease, Vitamin D Research Studies. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 8 companies, 5 NIH-funded awards (2013–2016).
- Most recent indexed publication: 2026 · Clinical journal of the American Society of Nephrology
- Top research focus: Parathyroid Disorders and Treatments
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 8 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 23 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 246.
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:
- CardioRenal Effects of SGLT2 Inhibition in Kidney Transplant Recipients
Sponsor: Duke University
InvestigatorPhase 2TerminatedNCT04906213 - HiLo: Pragmatic Trial of Higher vs Lower Serum Phosphate Targets in Patients Undergoing Hemodialysis
Sponsor: Duke University
InvestigatorTerminatedNCT04095039 - Fibroblast Growth Factor-23 (FGF23) Reduction in Predialysis Chronic Kidney Disease (CKD)
Sponsor: Myles Wolf
InvestigatorCompletedNCT00843349
Industry payments
Updated 14 Jul 2026
8 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- AKEBIA THERAPEUTICS INCProgram year202532 payments$396,948openpaymentsdata.cms.gov ↗
- CSL BehringProgram year202527 payments$52,811openpaymentsdata.cms.gov ↗
- Pharmacosmos Therapeutics Inc.Program year20254 payments$13,175openpaymentsdata.cms.gov ↗
NIH funding
Updated 14 Jul 2026
5 NIH research awards on record, funded 2013–2016 per NIH RePORTER. The latest:
- Tissue-Specific Regulation and Effects of CYP24A1
Weill Medical Coll of Cornell Univ
FY2026$552,426R01DK132060 - Tissue-Specific Regulation and Effects of CYP24A1
Weill Medical Coll of Cornell Univ
FY2025$417,559R01DK132060
Congress activity
Updated 14 Jul 2026
1 congress contribution (2020) across ASH per OpenAlex. The most recent:
- Persistent Hypophosphatemia after Ferric Carboxymaltose Is Associated with Persistent Changes in Biomarkers of Bone Metabolism
ASH Annual Meeting
ASH2020Presenting author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Fibroblast Growth Factor 23 Trajectories in Children and Association with CKD Progression: The CKD in Children Study.
Clinical journal of the American Society of Nephrology
2026 - Cardiovascular Outcomes among New Users of GLP-1 Receptor Agonists Compared with DPP-4 Inhibitors and Sulfonylureas in Kidney Failure.
Journal of the American Society of Nephrology
2026 - Effect of Clazakizumab on Neutrophil-Lymphocyte Ratio in Patients Receiving Hemodialysis: Secondary Analysis of the POSIBIL6ESKD Phase 2b Trial.
Clinical journal of the American Society of Nephrology
2026 - Higher versus Lower Phosphate Targets for Patients Undergoing In-Center Hemodialysis: A Randomized Controlled Trial.
Journal of the American Society of Nephrology
2025 - Effects of Lowering Dietary Phosphorus Additive Intake on Mineral Metabolism in Adults with and without CKD.
Clinical journal of the American Society of Nephrology
2025
Most-cited worksby citation count (OpenAlex)
- 01Vitamin D Deficiency and Risk of Cardiovascular Disease2,392 citations2008
- 02FGF23 induces left ventricular hypertrophy1,999 citations2011
- 03
- 04
- 05
Contact
No public contact details on file. This person's NPPES record doesn't include a practice address or telephone number. Why? →
Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- BA
Biology, The Johns Hopkins University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.weill.cornell.edu ↗ - MD
SUNY Downstate Health Sciences University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.weill.cornell.edu ↗ - Master of Medical Sciences (Clinical and Physiological Investigation)
Harvard Medical School
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.weill.cornell.edu ↗ - Internal medicine residency
Massachusetts General Hospital; clinical fellowship in nephrology, Massachusetts General Hospital and Brigham and Women's Hospital; research fellowship in nephrology …
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.weill.cornell.edu ↗
Editorial & leadership rolesjournal and society appointments
- Editorial board member
Journal of the American Society of Nephrology (JASN), Clinical Journal of the American Society of Nephrology (CJASN), Seminars in Nephrology, and Nature Reviews Nephrology; Editor …
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →asn-online.org ↗
Awards & honorshonors on the public record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.weill.cornell.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.weill.cornell.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.weill.cornell.edu ↗
Secondary affiliationsappointments beyond the home institution
- Prior: Chief
Division of Nephrology and Charles Johnson, MD Distinguished Professor of Medicine, Duke University School of Medicine; Nephrology Therapeutic Area Leader, Duke Clinical Research Institute (2016-2024 …
2024verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.weill.cornell.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.weill.cornell.edu ↗
- Board of Directors
Akebia Therapeutics, Inc. (publicly traded biopharmaceutical company; role stated as 'Chief of Nephrology and Professor at Duke University School of Medicine' in the appointment release)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →prnewswire.com ↗
Media & interviewspress, podcasts and appearances
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →asn-online.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/myles-wolf-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - Other
asn-online.org/about/bio.aspx
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asn-online.org ↗ - Other
asn-online.org/about/bio.aspx
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →asn-online.org ↗
Mentions by otherswhere others cite or feature them
- LinkedIn
linkedin.com/posts/robert-a-harrington-11160369_dr-myles-wolf-appointed-chair-of-medicine-activity-7213627621761327104-7vmF
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Jedd Wolchok, MD
Weill Cornell Medicine
- 1,448
- publications
- 176
- h-index
- 10
- trials
Ronald Crystal, MD
Weill Cornell Medicine
- 1,093
- publications
- 155
- h-index
- 43
- trials
Roy Gulick, MD, MPH
Weill Cornell Medicine
- 282
- publications
- 63
- h-index
- 7
- trials
Parag Goyal, MD
Weill Cornell Medicine
- 453
- publications
- 44
- h-index
- 10
- trials